Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt · Delayed Price · Currency is EGP 6.10
-0.15 (-2.40%)
At close: Sep 14, 2026
EGX:RMDA Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, EGX:RMDA stock has a consensus rating of "Buy" and an average price target of E£5.75. The average 1-year stock price forecast is 5.74% lower than the current stock price, while the lowest is E£4.40 (-27.87%) and the highest is E£8.00 (+31.15%).
Price Target: E£5.75 (-5.74%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for EGX:RMDA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 1 | 2 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Financial Forecast
Revenue This Year
4.84B
from 4.10B
Increased by 18.23%
Revenue Next Year
5.66B
from 4.84B
Increased by 16.89%
EPS This Year
0.25
from 0.13
Increased by 87.13%
EPS Next Year
0.37
from 0.25
Increased by 49.33%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EGP.